Dow Jones

39,137.46

0.02%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

DRTX

(MM) (DRTX)

(MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DRTX

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
12/12/2014	13:42	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:DRTX	(MM)
28/11/2014	08:56	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:DRTX	(MM)
19/11/2014	16:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)
19/11/2014	15:58	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DRTX	(MM)
19/11/2014	05:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:DRTX	(MM)
17/11/2014	15:47	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:DRTX	(MM)
17/11/2014	15:35	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:DRTX	(MM)
17/11/2014	15:18	Edgar (US Regulatory)	(25-NSE)	NASDAQ:DRTX	(MM)
17/11/2014	14:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRTX	(MM)
17/11/2014	07:33	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:DRTX	(MM)
17/11/2014	07:23	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:DRTX	(MM)
17/11/2014	07:00	PR Newswire (US)	Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer	NASDAQ:DRTX	(MM)
07/11/2014	06:50	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DRTX	(MM)
31/10/2014	15:15	PR Newswire (US)	Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata	NASDAQ:DRTX	(MM)
17/10/2014	15:48	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:DRTX	(MM)
17/10/2014	11:12	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:DRTX	(MM)
14/10/2014	11:36	Business Wire	INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Durata Therapeutics Inc. Concerning...	NASDAQ:DRTX	(MM)
11/10/2014	06:05	Business Wire	SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Durata Therapeutics, Inc. in Connection with the Sale of t...	NASDAQ:DRTX	(MM)
10/10/2014	17:45	PR Newswire (US)	DURATA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Durata Therapeutics Inc. (DRTX) Over the Propos...	NASDAQ:DRTX	(MM)
10/10/2014	16:31	Business Wire	DURATA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout	NASDAQ:DRTX	(MM)
10/10/2014	16:25	Business Wire	SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Durata Therapeutics, Inc. And Encourages ...	NASDAQ:DRTX	(MM)
09/10/2014	19:20	PR Newswire (US)	Harwood Feffer LLP Announces Investigation of Durata Therapeutics, Inc.	NASDAQ:DRTX	(MM)
08/10/2014	05:07	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:DRTX	(MM)
07/10/2014	17:29	PR Newswire (US)	Lifshitz & Miller Law Firm Announces Investigation of Altair Nanotechnologies, Inc., CareFusion, Durata Therapeutics, Inc., E...	NASDAQ:DRTX	(MM)
07/10/2014	15:34	PR Newswire (US)	INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Durata Therapeutics Inc. Regarding the...	NASDAQ:DRTX	(MM)
07/10/2014	09:45	PR Newswire (US)	Ryan & Maniskas, LLP Announces Investigation of Durata Therapeutics, Inc.	NASDAQ:DRTX	(MM)
06/10/2014	18:15	Business Wire	DURATA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Durata Therapeutics Inc. (DRTX) over the Propos...	NASDAQ:DRTX	(MM)
06/10/2014	17:18	Dow Jones News	U.S. Hot Stocks: Hot Stocks to Watch	NASDAQ:DRTX	(MM)
06/10/2014	16:11	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:DRTX	(MM)
06/10/2014	12:22	Business Wire	Glancy Binkow & Goldberg LLP is Investigating Durata Therapeutics, Inc. Board of Directors	NASDAQ:DRTX	(MM)